SSC 18 - SSC Session - Hemostasis & Malignancy

Presentations:

• 4:30 PM – 4:35 PM

  Introduction
  

  Speaker: Jeffrey Zwicker, MD – Beth Israel Deaconess Medical Center
• 4:35 PM – 4:45 PM

  Risk Assessment Models to Predict Cancer-associated Thrombosis (CAT)
  

  Speaker: Kristen Sanfillipo, MD, MPHS – Washington University St. Louis School of Medicine
• 4:45 PM – 4:55 PM

  Risk Assessment Modeling of Thrombosis in Acute Lymphocytic Leukemia (ALL)
  

  Speaker: Avi Leader, MD – Institute of Hematology, Rabin Medical Center, Petah Tikva
• 4:55 PM – 5:05 PM

  What Have Mouse Models of Cancer-associated Thrombosis (CAT) Taught Us?
  

  Speaker: Laurence Panicot-Dubois, PhD – Aix Marseille University, INSERM 1263, INRAE, C2VN, Marseille, France
• 5:05 PM – 5:15 PM

  Q&A
  

  Speaker: Kristen Sanfillipo, MD, MPHS – Washington University St. Louis School of Medicine

  Speaker: Jeffrey Zwicker, MD – Beth Israel Deaconess Medical Center
• 5:15 PM – 5:25 PM

  Anticoagulation and Hemostasis Guidance Prior to Cancer Procedures
  

  Speaker: Tzu-Fei Wang, MD, MPH – Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada
• 5:25 PM – 5:35 PM

  Thrombotic Complications of Breast Cancer Treatments Including Endocrine Therapy
  

  Speaker: Cliona Clare Kirwan, MBBS FRCS PhD – University of Manchester
• 5:35 PM – 5:45 PM

  Chimeric Antigen Receptor T-cell (CAR-T) Therapy Associated Coagulopathy
  

  Speaker: Rushad Patell, MD – Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA
• 5:45 PM – 5:55 PM

  Thrombopoietin (TPO)-Mimetics and Thrombocytopenia in Cancer
  

  Speaker: Gerald A. Soff, MD – University of Miami Health System/Sylvester Comprehensive Cancer Center
• 5:55 PM – 6:05 PM

  Q&A
  

  Speaker: Jeffrey Zwicker, MD – Beth Israel Deaconess Medical Center

  Speaker: Kristen Sanfillipo, MD, MPHS – Washington University St. Louis School of Medicine
• 6:05 PM – 6:15 PM

  Past and Future of Cancer Associated Thrombosis
  

  Speaker: Anna Falanga, MD (she/her/hers) – Department of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy
• 6:15 PM – 6:25 PM

  Overview of Funding Options for Clinical Trials in Cancer-associated Thrombosis (CAT)
  

  Speaker: Marc Carrier, MD – Ottawa Hospital Research Institute, Ottawa, ON, Canada
• 6:25 PM – 6:30 PM

  Conclusion
  

  Speaker: Anthony Maraveyas, MD – Hull University Teaching Hospital NHS Trust, UK